Thomas Berg

2 ta ish

Charit -Campus Virchow Klinikum, Berlin, Germany;

1. 49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

   Jordi Bruix, Thierry Poynard, Massimo Colombo +16

   MaqolaHepatocellular Carcinoma Treatment and PrognosisJournal of Hepatology20090 iqtibos

   ABIABI:AkademIndex/openalex/2009.article.000125

2. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

   Homie Razavi, Imam Waked, Huma Qureshi +97

   MaqolaHepatitis C virus researchJournal of Hepatology20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.000135